Cardiac Dysfunction in Severely Burned Patients: Current Understanding of Etiology, Pathophysiology, and Treatment.
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
pubmed:
19
10
2019
medline:
2
6
2021
entrez:
19
10
2019
Statut:
ppublish
Résumé
Patients who experience severe burn injuries face a massive inflammatory response resulting in hemodynamic and cardiovascular complications. Even after immediate and appropriate resuscitation, removal of burn eschar and covering of open areas, burn patients remain at high risk for serious morbidity and mortality. As a result of the massive fluid shifts following the initial injury, along with large volume fluid resuscitation, the cardiovascular system is critically affected. Further, increased inflammation, catecholamine surge, and hypermetabolic syndrome impact cardiac dysfunction, which worsens outcomes of burn patients. This review aimed to summarize the current knowledge about the effect of burns on the cardiovascular system.A comprehensive search of the PubMed and Embase databases and manual review of articles involving effects of burns on the cardiovascular system was conducted.Many burn units use multimodal monitors (e.g., transpulmonary thermodilution) to assess hemodynamics and optimize cardiovascular function. Echocardiography is often used for additional evaluations of hemodynamically unstable patients to assess systolic and diastolic function. Due to its noninvasive character, echocardiography can be repeated easily, which allows us to follow patients longitudinally.The use of anabolic and anticatabolic agents has been shown to be beneficial for short- and long-term outcomes of burn survivors. Administration of propranolol (non-selective β-receptor antagonist) or oxandrolone (synthetic testosterone) for up to 12 months post-burn counteracts hypermetabolism during hospital stay and improves cardiac function.A comprehensive understanding of how burns lead to cardiac dysfunction and new therapeutic options could contribute to better outcomes in this patient population.
Identifiants
pubmed: 31626036
doi: 10.1097/SHK.0000000000001465
pii: 00024382-202006000-00002
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
669-678Références
Keck M, Herndon DN, Kamolz LP, Frey M, Jeschke MG. Pathophysiology of burns. Wien Med Wochenschr 159:327–336, 2009.
Paratz JD, Stockton K, Paratz ED, Blot S, Muller M, Lipman J, Boots RJ. Burn resuscitation—hourly urine output versus alternative endpoints: a systematic review. Shock 42 (4):295–306, 2014.
Baxter CR. Management of fluid volume and electrolyte changes in the early postburn period. Geriatrics 30 (11):57–62, 1975.
Wolfe RR, Miller HI. Cardiovascular and metabolic responses during burn shock in the guinea pig. Am J Physiol 231 (3):892–897, 1976.
Ganrot K, Jacobsson S, Rothman U. Transcapillary passage of plasma proteins in experimental burns. Acta Physiol Scand 91 (4):497–501, 1974.
Williams FN, Herndon DN, Suman OE, Lee JO, Norbury WB, Branski LK, Mlcak RP, Jeschke MG. Changes in cardiac physiology after severe burn injury. J Burn Care Res 32 (2):269–274, 2011.
Baxter CR, Cook WA, Shires GT. Serum myocardial depressant factor of burn shock. Surg Forum 17:1–2, 1966.
Abu-Sittah GS, Sarhane KA, Dibo SA, Ibrahim A. Cardiovascular dysfunction in burns: review of the literature. Ann Burns Fire Disasters 25 (1):26–37, 2012.
Kaufman TM, Horton JW. Burn-induced alterations in cardiac beta-adrenergic receptors. Am J Physiol 262 (5 pt 2):H1585–H1591, 1992.
Maass DL, White J, Horton JW. IL-1 and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18 (4):360–366, 2002.
Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97 (14):1375–1381, 1998.
Pruitt BA, Mason AD, Moncrief JA. Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine). J Trauma 11 (1):36–46, 1971.
Papp A, Uusaro A, Parviainen I, Hartikainen J, Ruokonen E. Myocardial function and haemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography and cytokine concentrations. A prospective clinical study. Acta Anaesthesiol Scand 47 (10):1257–1263, 2003.
Miller JG, Bunting P, Burd DA, Edwards JD. Early cardiorespiratory patterns in patients with major burns and pulmonary insufficiency. Burns 20 (6):542–546, 1994.
Bailey B, Gaudreault P, Thivierge RL. Cardiac monitoring of high-risk patients after an electrical injury: a prospective multicentre study. Emerg Med J 24 (5):348–352, 2007.
Adams HR, Baxter CR, Izenberg SD. Decreased contractility and compliance of the left ventricle as complications of thermal trauma. Am Heart J 108 (6):1477–1487, 1984.
Hundeshagen G, Herndon DN, Clayton RP, Wurzer P, McQuitty A, Jennings K, Branski L, Collins VN, Marques NR, Finnerty CC, et al. Long-term effect of critical illness after severe paediatric burn injury on cardiac function in adolescent survivors: an observational study. Lancet Child Adolesc Health 1 (4):293–301, 2017.
Crossman DC. The pathophysiology of myocardial ischaemia. Heart 90 (5):576–580, 2004.
Kinsky MP, Guha SC, Button BM, Kramer GC. The role of interstitial starling forces in the pathogenesis of burn trauma. J Burn Care Rehabil 19 (1):1–9, 1998.
Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet 363 (9424):1895–1902, 2004.
Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Ferrando AA, Wolfe RR, Herndon DN. Persistence of muscle catabolism after severe burn. Surgery 128 (2):312–319, 2000.
Wolfe RR. Review: acute versus chronic response to burn injury. Circ Shock 8 (1):105–115, 1981.
Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 139 (6):641–647, 2004.
Dickerson RN, Gervasio JM, Riley ML, Murrell JE, Hickerson WL, Kudsk KA, Brown RO. Accuracy of predictive methods to estimate resting energy expenditure of thermally-injured patients. JPEN J Parenter Enteral Nutr 26 (1):17–29, 2002.
Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 (17):1223–1229, 2001.
Lefer AM. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock. Klin Wochenschr 60 (14):713–716, 1982.
Chiao JJ, Minei JP, Shires GT 3rd, Shires GT. In vivo myocyte sodium activity and concentration during hemorrhagic shock. Am J Physiol 258 (3 pt 2):R684–R689, 1990.
Hagiwara S, Iwasaka H, Uchino T, Noguchi T. High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J 72 (6):1012–1017, 2008.
American Burn Association. ABA Annual Burn Repository. 2016 [10/19/2017]; Available at: http://www.ameriburn.org/NBR.php.
Ghavami Y, Mobayen MR, Vaghardoost R. Electrical burn injury: a five-year survey of 682 patients. Trauma Mon 19 (4):e18748, 2014.
Koumbourlis AC. Electrical injuries. Crit Care Med 30: (11 suppl): S424–S430, 2002.
Housinger TA, Green L, Shahangian S, Saffle JR, Warden GD. A prospective study of myocardial damage in electrical injuries. J Trauma 25 (2):122–124, 1985.
Zubair M, Besner GE. Pediatric electrical burns: management strategies. Burns 23 (5):413–420, 1997.
Arrowsmith J, Usgaocar RP, Dickson WA. Electrical injury and the frequency of cardiac complications. Burns 23 (7–8):576–578, 1997.
Jackson SH, Parry DJ. Lightning and the heart. Br Heart J 43 (4):454–457, 1980.
Sinha AK. Lightning-induced myocardial injury. A case report with management. Angiology 36 (5):327–331, 1985.
Kravitz H, Wasserman MJ, Valaitis JJ, Anzinger RE, Naidu SH. Lightning injury: management of a case with ten-day survival. Am J Dis Child 131 (4):413–415, 1977.
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur J Echocardiogr 29 (4):277–314, 2016.
Wright P, Thomas M. Pathophysiology and management of heart failure. Clin Pharmacist 10 (12):1–3, 2018.
Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 37 (4):1042–1048, 2001.
Lin CY, Wu CK, Yeong EK, Lin HH, Huang YT, Lee JK, Lin YH, Chiang FT, Tang YB, Tsai CT. Prognostic significance of left ventricular diastolic function in burn patients. Shock 37 (5):457–462, 2012.
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35 (6):1599–1608, 2007.
Xiao R, Lei Z-Y, Dang Y-M, Huang Y-S. Prompt myocardial damage contributes to hepatic, renal, and intestinal injuries soon after a severe burn in rats. J Trauma 71 (3):663–672, 2011.
Murphy JT, Horton JW, Purdue GF, Hunt JL. Evaluation of troponin-I as an indicator of cardiac dysfunction after thermal injury. J Trauma 45 (4):700–704, 1998.
Huang YS, Yang ZC, Yan BG, Yang JM, Chen FM, Crwother RS, Li A. Pathogenesis of early cardiac myocyte damage after severe burns. J Trauma 46 (3):428–432, 1999.
Horton JW. A model of myocardial inflammation and dysfunction in burn complicated by sepsis. Shock 28 (3):326–333, 2007.
Tao W, Maass DL, Johnston WE, Horton JW. Murine in vivo myocardial contractile dysfunction after burn injury is exacerbated by pneumonia sepsis. Shock 24 (5):495–499, 2005.
Martyn JA, Snider MT, Szyfelbein SK, Burke JF, Laver MB. Right ventricular dysfunction in acute thermal injury. Ann Surg 191 (3):330–335, 1980.
Sugi K, Theissen JL, Traber LD, Herndon DN, Traber DL. Impact of carbon monoxide on cardiopulmonary dysfunction after smoke inhalation injury. Circ Res 66 (1):69–75, 1990.
Cioffi WG, DeMeules JE, Gamelli RL. The effects of burn injury and fluid resuscitation on cardiac function in vitro. J Trauma 26 (7):638–642, 1986.
Demling RH, Mazess RB, Witt RM, Wolberg WH. The study of burn wound edema using dichromatic absorptiometry. J Trauma 18 (2):124–128, 1978.
Li Y, Ge S, Peng Y, Chen X. Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis. Burns Trauma 1 (3):109–121, 2013.
Barke RA, Roy S, Chapin RB, Charboneau R. The role of programmed cell death (apoptosis) in thymic involution following sepsis. Arch Surg 129 (12):1256–1261, 1994.
Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 25 (8):1298–1307, 1997.
Matsuura H, Matsumoto H, Osuka A, Ogura H, Shimizu K, Kang S, Tanaka T, Ueyama M, Shimazu T. Clinical importance of a cytokine network in major burns. Shock 51 (2):185–193, 2019.
Eichenholz PW, Eichacker PQ, Hoffmann WD, Banks SM, Parrillo JE, Danner RL, Natanson C. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 263 (3):668–675, 1992.
Maass DL, White J, Horton JW. Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function. Crit Care Med 33 (12):2794–2803, 2005.
Heard SO, Perkins MW, Fink MP. Tumor necrosis factor-alpha causes myocardial depression in guinea pigs. Crit Care Med 20 (4):523–527, 1992.
Sheeran PW, Maass DL, White DJ, Turbeville TD, Giroir BP, Horton JW. Aspiration pneumonia- induced sepsis increases cardiac dysfunction after burn trauma. J Surg Res 76 (2):192–199, 1998.
Liu XS, Yang ZC, Luo ZH, Huang WH, Li A. A preliminary exploration of the relationship between tumor necrosis factor (TNF) and monocytic in vitro production of interleukin-1 (IL-1) and internal organ dysfunction in severely burned patients. Burns 21 (1):29–33, 1995.
Liu XS, Luo ZH, Yang ZC, Huang WH, Li AN. The significance of changes in serum tumor necrosis factor activity in severely burned patients. Burns 20 (1):40–44, 1994.
Cannon JG, Friedberg JS, Gelfand JA, Tompkins RG, Burke JF, Dinarello CA. Circulating interleukin 1-β and Tumor necrosis factor-α concentrations after a burn in humans. Crit Care Med 20 (10):1414–1419, 1992.
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative ionotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (5068):387–389, 1992.
Horton JW, Maass DL, White DJ, Sanders B, Murphy J. Effects of burn serum on myocardial inflammation and function. Shock 22 (5):438–445, 2004.
Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH. Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function. Crit Care Med 27 (7):1309–1318, 1999.
Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (3):949–958, 1996.
Horton JW, Maass DL, White J, Sanders B. Nitric oxide modulation of TNF-α-induced cardiac contractile dysfunction is concentration dependent. Am J Physiol 278:H1955–H1965, 2000.
Maass DL, Hybki DP, White J, Horton JW. The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction. Shock 17 (4):293–299, 2002.
Davis AM, Natelson BH. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Tex Heart Inst J 20 (3):158–169, 1993.
Minifee P, Barrow BE, Abston S, Desai CS, Herndon DN. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg 24 (8):806–810, 1989.
Raab W. Key position of catecholamines in functional and degenerative cardiovascular pathology. Am J Cardiol 5:571–578, 1960.
Kulp GA, Herndon DN, Lee JO, Suman OE, Jeschke MG. Extent and magnitude of catecholamine surge in pediatric burned patients. Shock 33 (4):369–374, 2010.
Goldstein DS. Catecholamines and stress. Endocr Requl 37 (2):69–80, 2003.
Doughterty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol 54 (7):778–782, 1984.
Desai CS, Colangelo LA, Liu K, Jacobs DRJ, Cook NL, Lloyd-Jones DM, Ogunyankin KO. Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study. Am J Epidemiol 177 (1):20–32, 2013.
Kasper SO, Castle SM, Daley BJ, Enderson BL, Karlstad MD. Blockade of the renin-angiotensin system improves insulin sensitivity in thermal injury. Shock 26 (5):485–488, 2006.
Duke JM, Randall SM, Fear MW, Boyd JH, Rea S, Wood FM. Understanding the long-term impacts of burn on the cardiovascular system. Burns 42 (2):366–374, 2016.
Müller K, Gamba G, Jaquet F, Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV—efficacy and quality of life. Eur J Heart Fail 5 (6):793–801, 2003.
Chen YN, Luo ZR, Zeng LJ, Wu MY, Wu YZ, Lin ZY. Cardiac troponin I: a marker for post-burn cardiac injury. Ann Clin Biochem 37 (4):447–451, 2000.
Gosling P, Bascom JU, Zikria BA. Capillary leak, oedema and organ failure: breaking the triad. Care Crit Ill 12:191–197, 1996.
Singer AJ, Jurukovski V, Simon M, Protter A, Arura B, Soroff HS. The presence of B-type natriuretic peptide in burns and the responsiveness of fibroblasts to BNP: proof of principle. Acad Emerg Med 14 (6):503–507, 2007.
Luchner A, Stevens TL, Borgeson DD, Redfield M, Wei CM, Porter JG, Burnett JCJ. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274 (5):1684–1689, 1998.
Lindahl AE, Stridsberg M, Sjöberg F, Ekselius L, Gerdin B. Natriuretic peptide type B in burn intensive care. J Trauma Acute Care Surg 74 (3):855–861, 2013.
de Leeuw K, Nieuwenhuis MK, Niemeijer AS, Eshuis H, Beerthuizen G, Janssen WM. Increased B-type natriuretic peptide and decreased proteinuria might reflect decreased capillary leakage and is associated with a better outcome in patients with severe burns. Crit Care 15 (4):R161, 2011.
Ramsingh D, Alexander B, Cannesson M. Clinical review: does it matter which hemodynamic monitoring system is used? Crit Care 17 (2):208, 2013.
Connors AFJ, Speroff T, Dawson NV, Thomas C, Harrell FEJ, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276 (11):889–897, 1996.
Ikuta K, Wang Y, Robinson A. National trends in use and outcomes of pulmonary artery catheters among medicare beneficiaries. JAMA Cardiol 2 (8):908–913, 2017.
Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (13):1625–1633, 2005.
Khera R, Pandey A, Kumar N, Singh R, Bano S, Golwala H, Kumbhani DJ, Girotra S, Fonarow GC. Variation in hospital use and outcomes associated with pulmonary artery catheterization in heart failure in the United States. Circ Heart Fail 9 (11):e003226, 2016.
Branski LK, Herndon DN, Byrd JF, Kinsky MP, Lee JO, Fagan SP, Jeschke MG. Transpulmonary thermodilution for hemodynamic measurements in severely burned children. Crit Care Med 15 (2):R118, 2011.
Wurzer P, Branski LK, Jeschke MG, Ali A, Kinsky MP, Bohanon FJ, Hundeshagen G, Norbury WB, Williams FN, Kamolz LP, et al. Transpulmonary thermodilution versus transthoracic echocardiography for cardiac output measurements in severely burned children. Shock 46 (3):249–523, 2016.
Olesen LL, Andersen A. ECG as a first step in the detection of left ventricular systolic dysfunction in the elderly. ESC Heart Fail 3 (1):44–52, 2016.
Nielsen OW, Hansen JF, Hilden J, Larsen CT, Svanegaard J. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ 320 (7229):220–224, 2000.
Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Zuithoff NP, Liem AH, Hoes AW. Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail 17 (2):187–195, 2015.
Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (23):2932–2937, 2003.
Gillespie ND. The diagnosis and management of chronic heart failure in the older patient. Br Med Bull 75–76 (1):49–62, 2005.
Sheifer SE, Gersh BJ, Yanez NDr, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 35 (1):119–126, 2000.
Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, Brugger H, Deakin CD, Dunning J, Georgiou M, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 81 (10):1400–1433, 2010.
Morales MA, Prediletto R, Rossi G, Catapano G, Lombardi M, Rovai D. Routine chest X-ray: still valuable for the assessment of left ventricular size and function in the Era of super machines? J Clin Imaging Sci 2:25, 2012.
Kleber FX, Niemöller L, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol 68 (14):121D–126D, 1991.
George A, Gupta R, Bang RL, Ebrahim MK. Radiological manifestation of pulmonary complications in deceased intensive care burn patients. Burns 29 (1):73–78, 2003.
Earls JP, Ho VB, Foo TK, Castillo E, Flamm SD. Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging 16 (2):111–127, 2002.
Selton-Suty C, Juillière Y. Non-invasive investigations of the right heart: how and why? Arch Cardiovasc Dis 102 (3):219–232, 2009.
Poth JM, Beck DR, Bartels K. Ultrasonography for haemodynamic monitoring. Best Pract Res Clin Anaesthesiol 28:337–351, 2014.
Maass DL, Naseem RH, Garry M, Horton JW. Echocardiography assessment of myocardial function after burn injury. Shock 25 (4):363–369, 2006.
Lemson J, Nusmeier A, van der Hoeven JG. Advanced hemodynamic monitoring in critically ill children. Pediatrics 128 (3):560–571, 2011.
Weekens AJ, Reddy A, Lewis MR, Norton HJ. E-point septal separation compared to fractional shortening measurements of systolic function in emergency department patients: prospective randomized study. J Ultrasound Med 31 (12):1891–1897, 2012.
Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Euro Heart J 26:1115–1140, 2005.
Bobbia X, Muller L, Claret PG, Vigouroux L, Perez-Martin A, Coussaye JE, Lefrant JY, Louart G, Roger C, Markarian T. A new echocardiographic tool for cardiac output evaluation: an experimental study. Shock 52:449–455, 2019.
Howard TS, Hermann DG, McQuitty AL, Woodson LC, Kramer GC, Herndon DN, Ford PM, Kinsky MP. Burn-induced cardiac dysfunction increases length of stay in pediatric burn patients. J Burn Care Res 34 (4):413–419, 2013.
O’Halloran E, Shah A, Dembo L, Hool L, Viola H, Grey C, Boyd J, O’Neill T, Wood F, Duke J, et al. The impact of non-severe burn injury on cardiac function and long-term cardiovascular pathology. Sci Rep 3 (6):1–11, 2016.
Peña R, Ramirez LB, Crandall CG, Wolf S, Herndon DN, Suman OE. Effects of community-based exercise in children with severe burns: a randomized trial. Burns 42 (1):41–47, 2016.
Abdullahi A, Jeschke MG. Nutrition and anabolic pharmacotherapies in the care of burn patients. Nutr Clin Pract 29 (5):621–630, 2014.
Rojas Y, Finnerty CC, Radhakrishnan RS, Herndon DN. Burns: an update on current pharmacotherapy. Expert Opin Pharmacother 13 (17):2485–2494, 2012.
Guillory AN, Clayton RP, Herndon DN, Finnerty CC. Cardiovascular dysfunction following burn injury: what we have learned from rat and mouse models. Int J Mol Sci 17 (1):E53, 2016.
Herndon DN, Barrow BE, Rutan TC, Minifee P, Jahoor F, Wolfe RR. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg 208 (4):484–492, 1988.
Wurzer P, Branski LK, Clayton RP, Hundeshagen G, Forbes AA, Andersen CR, Kamolz LP, Woodson LC, Suman OE, Finnerty CC, et al. Propranolol reduces cardiac index but does not adversely affect peripheral perfusion in severely burned children. Shock 46 (5):486–491, 2016.
Williams FN, Herndon DN, Kulp GA, Jeschke MG. Propranolol decreases cardiac work in a dose-dependent manner in severely burned children. Surgery 149 (2):231–239, 2011.
Herndon DN, Rodriguez NA, Diaz EC, Hegde S, Jennings K, Mlcak RP, Suri JS, Lee JO, Williams FN, Meyer W, et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg 256 (3):402–411, 2012.
Wilmore DW, Long JM, Mason ADJ, Skree RW, Pruitt BAJ. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 180 (4):653–669, 1974.
Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 43 (3):474–484, 2006.
Mecott GA, Al-Mousawi AM, Gauglitz GG, Herndon DN, Jeschke MG. The role of hyperglycemia in burned patients: evidence-based studies. Shock 33 (1):5–13, 2010.
Lu GF, Shi HW, Wang GY, Fan L, Hu DH, Chen B. The protective effects of insulin on cardiocyte apoptosis challenged by burn serum. Chinese Crit Care Med 24 (4):197–200, 2012.
Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, Wolfe RR, Herndon DN. Anabolic effects of oxandrolone after severe burn. Ann Surg 233 (4):556–564, 2001.
Cochran A, Thuet W, Holt B, Smout RJ, Horn SD. The impact of oxandrolone on length of stay following major burn injury: a clinical practice evaluation. Burns 39 (7):1374–1379, 2013.
Porro LJ, Herndon DN, Rodriguez NA, Jennings K, Klein GL, Mlcak RP, Meyer W, Lee J, Suman OE, Finnerty CC. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg 214 (4):489–504, 2012.
Reeves PT, Herndon DN, Tanksley JD, Jennings K, Klein GL, Mlcak RP, Clayton RP, Crites NN, Hays JP, Andersen C, et al. Five-year outcomes after long-term oxandrolone administration in severely burned children: a randomized clinical trial. Shock 45 (4):367–374, 2016.
Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2):289–296, 2007.
Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat Rev Endocrinol 8 (12):743–754, 2012.
Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (6785):458–462, 2000.
Mioni C, Bazzani C, Giuliani D, Altavilla D, Leone S, Ferrari A, Minutoli L, Bitto A, Marini H, Zaffe D, et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 33 (11):2621–2628, 2005.
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (6921):384–388, 2003.
Tracey KJ. The inflammatory reflex. Nature 420 (6917):853–859, 2002.